financetom
Business
financetom
/
Business
/
What's Going On With Plug Power Shares Wednesday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Plug Power Shares Wednesday?
Mar 27, 2024 5:40 AM

Plug Power, Inc. ( PLUG ) shares are trading higher in the premarket session on Wednesday.

In an exchange filing, the company said it issued $140.396 million in aggregate principal amount of its 7% convertible senior notes due 2026 under an indenture dated March 20, 2024, between the company and Wilmington Trust, National Association, as trustee.

The new notes were issued in exchange for $138.816 million in aggregate principal amount of the company’s 3.75% convertible senior notes due 2025.

Following the closing of the exchange transactions, approximately $58.5 million in aggregate principal amount of 2025 notes remain outstanding with terms unchanged. 

The initial conversion rate for the new notes will be 235.40 shares of common stock per $1,000 principal amount of new notes, which represents an initial conversion price of approximately $4.25 per share of common stock and is subject to adjustment upon the occurrence of certain specified events as set forth in the indenture.

The new notes will mature on June 1, 2026, unless earlier converted, redeemed or repurchased in accordance with their terms.

Earlier this month, the company reported fiscal 2023 net revenue growth of 27.1% year-over-year to $891.234 million, missing the consensus of $900.29 million. Net loss per share was $(2.30), below the consensus of $(1.61).

Plug Power ( PLUG ) held cash and equivalents of $1.169 billion as of December 31, 2023.

Check This Out: Why Is NIO Stock Trading Lower Today?

According to Benzinga Pro, PLUG stock has lost over 69% in the past year. Investors can gain exposure to the stock via Global X Hydrogen ETF ( HYDR ) and ETF Series Solutions Defiance Next Gen H2 ETF .

Price Action: PLUG shares are trading higher by 1.31% to $3.270 premarket on the last check Wednesday. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HLS Therapeutics Narrows Q3 Loss as Vascepa Scripts Climb
HLS Therapeutics Narrows Q3 Loss as Vascepa Scripts Climb
Nov 13, 2025
07:43 AM EST, 11/13/2025 (MT Newswires) -- HLS Therapeutics ( HLTRF ) said Thursday that third-quarter net loss narrowed slightly as revenue rose. Net loss improved to US$3.92 million, or $0.12 per share, from a loss of $4.84 million, or $0.15 per share in the prior year period. Revenue decreased 4% to $13.5 million, primarily due to lower Clozaril Canada...
Fiera Capital Q3 revenue slightly misses estimates
Fiera Capital Q3 revenue slightly misses estimates
Nov 13, 2025
Overview * Fiera Capital ( FRRPF ) Q3 revenue slightly misses analyst expectations * Adjusted EPS for Q3 meets analyst estimates * Company achieved positive net organic growth in AUM, driven by new relationships Outlook * Company did not provide specific guidance for future quarters or full year Result Drivers * NET ORGANIC GROWTH - Positive net organic growth of...
Xilio Therapeutics' Q3 collaboration revenue rises
Xilio Therapeutics' Q3 collaboration revenue rises
Nov 13, 2025
Overview * Xilio Q3 collaboration revenue rises to $19.1 mln from $2.3 mln year-over-year * Net loss for Q3 widens to $16.3 mln from $14.0 mln year-over-year * Company anticipates cash runway into Q1 2027 Outlook * Xilio plans to submit IND for XTX501 in mid-2026 * Company anticipates cash runway into Q1 2027 * Xilio seeks partner for vilastobart...
Palatin fiscal Q1 revenue hits $8.8 mln, net income $4.7 mln
Palatin fiscal Q1 revenue hits $8.8 mln, net income $4.7 mln
Nov 13, 2025
Overview * Palatin fiscal Q1 2026 revenue rises to $8.8 mln, driven by Boehringer Ingelheim agreement * Company reports fiscal Q1 net income of $4.7 mln, reversing a loss from last year * Palatin ( PTN ) completes $18.2 mln public offering, regains NYSE American compliance Outlook * Company plans IND submission and Phase 1 trial for PL7737 in first...
Copyright 2023-2026 - www.financetom.com All Rights Reserved